수술용 봉합사 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2025-2034년)

Growth Factors of surgical sutures Market

The global surgical sutures market is witnessing steady growth driven by the rising number of surgical procedures, increasing prevalence of chronic diseases, and continuous advancements in suturing technologies. In 2025, the global surgical sutures market size was valued at USD 6.03 billion. The market is projected to grow from USD 6.42 billion in 2026 to USD 11.52 billion by 2034, registering a CAGR of 7.57% during the forecast period (2026-2034).

North America dominated the surgical sutures market with a 39.44% share in 2025, supported by a high volume of surgeries, advanced healthcare infrastructure, and strong presence of key market players.

Surgical sutures are medical devices used to close wounds and ligate blood vessels during or after surgical procedures. These products are extensively used in major surgeries such as cesarean sections, joint replacements, cardiovascular surgeries, and minor procedures including dental and ophthalmic surgeries. The growing incidence of road accidents, orthopedic injuries, and chronic disorders has significantly increased surgical volumes worldwide, thereby boosting demand for surgical sutures.

Market Drivers

Rising Number of Surgical Procedures

The increasing number of orthopedic, cardiovascular, gynecological, and cosmetic surgeries is a major factor driving market growth. For instance, data from the American College of Rheumatology (February 2023) indicates that approximately 790,000 knee replacement and 450,000 hip replacement surgeries are performed annually in the U.S.

Additionally, according to the CDC, 1,174,545 cesarean deliveries were recorded in the U.S. in 2021, accounting for 32.1% of all births. The expanding geriatric population, which is more prone to arthritis, fractures, and cardiovascular conditions, is further increasing surgical intervention rates and supporting market expansion.

Technological Advancements in Sutures

The introduction of advanced sutures, including knotless, elastic, and bio-composite sutures, is improving surgical outcomes and driving adoption. These sutures enable faster wound healing, reduced infection risk, and enhanced tensile strength. Continuous R&D investments and regulatory approvals for innovative products are positively influencing market growth.

Market Trends

Introduction of Advanced and Smart Sutures

One of the key trends in the market is the adoption of knotless and technologically advanced sutures designed to address unmet clinical needs. These sutures can deliver drugs, detect infections, and support efficient wound closure.

For instance, the U.S. FDA granted 510(k) clearance to several knotless suture systems, including Anika Therapeutics' X-Twist and Smith & Nephew's HELICOIL knotless sutures. Such advancements are enabling companies to strengthen their market position while expanding product portfolios.

Restraining Factors

Competition from Alternative Wound Closure Products

The availability of alternative wound care products such as surgical staplers poses a challenge to market growth. Staplers offer faster wound closure and reduced operation time. In addition, concerns related to surgical site infections (SSIs) associated with sutures and lack of reimbursement policies in emerging economies may limit adoption. According to NCBI data, approximately 5% of surgical patients develop SSIs annually, which impacts surgeon preference for sutures in certain procedures.

Segmentation Analysis

By Product Type

The market is segmented into absorbable and non-absorbable sutures.

The absorbable segment dominated with a 64.30% share in 2026, owing to faster healing, high tensile strength, and reduced need for stitch removal. Regulatory support further strengthens this segment's dominance.

By Form

Based on form, the market is divided into synthetic and natural sutures.

The synthetic segment accounted for 78.31% market share in 2026, attributed to lower hypersensitivity reactions and higher adoption by healthcare professionals.

By Application

The orthopedics segment led the market with a 27.40% share in 2026, driven by a rising number of joint replacement and fracture repair surgeries. Gynecology and cardiology also contribute significantly due to increasing cesarean and bypass procedures.

By End User

The hospitals & ASCs segment dominated with a 71.15% share in 2026, supported by high surgical volumes, advanced facilities, and skilled surgeons.

Regional Insights

• North America: Valued at USD 2.38 billion in 2025 and USD 2.53 billion in 2026, driven by chronic disease prevalence and product innovation.
• Europe: Growth supported by strong healthcare infrastructure and rising joint replacement surgeries.
• Asia Pacific: Expected to register the highest CAGR, driven by rising surgical volumes in China, India, and Japan.
• Latin America & Middle East & Africa: Moderate growth due to expanding medical tourism and increasing awareness.

Competitive Landscape

Key players include B. Braun SE, Ethicon U.S. LLC, Medtronic, Smith & Nephew, and Coloplast A/S. These companies focus on product innovation, capacity expansion, and strategic launches to strengthen their global presence.

Conclusion

In conclusion, the global surgical sutures market is projected to grow steadily from USD 6.03 billion in 2025 to USD 11.52 billion by 2034. Rising surgical volumes, technological advancements in suturing devices, and increasing geriatric population are the key growth drivers. Although competition from alternative wound closure products and infection-related concerns pose challenges, continuous innovation and expanding healthcare infrastructure worldwide are expected to sustain long-term market growth.

Segmentation

By Product Type

• Absorbable
• Non-absorbable

By Form

• Natural
• Synthetic

By Application

• Gynecology
• Orthopedics
• Cardiology
• General Surgery
• Others

By End-user

• Hospitals & ASCs
• Specialty Clinics

By Geography

• North America (By Product Type, Form, Application, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, Form, Application, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, Form, Application, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, Form, Application, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, Form, Application, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of Number of Surgical Procedures, for Key Countries, 2024/2025
• 4.2. Regulatory Scenario in Key Countries
• 4.3. Key Industry Developments - Mergers, Acquisition, Etc.
• 4.4. Impact of COVID-19 on the Surgical Sutures Market

5. Global Surgical Sutures Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Absorbable
  • 5.1.2. Non-Absorbable
• 5.2. Market Analysis, Insights and Forecast - By Form
  • 5.2.1. Natural
  • 5.2.2. Synthetic
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Gynecology
  • 5.3.2. Cardiology
  • 5.3.3. Orthopedics
  • 5.3.4. General Surgery
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Clinics
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Surgical Sutures Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Absorbable
  • 6.1.2. Non-Absorbable
• 6.2. Market Analysis, Insights and Forecast - By Form
  • 6.2.1. Natural
  • 6.2.2. Synthetic
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Gynecology
  • 6.3.2. Cardiology
  • 6.3.3. Orthopedics
  • 6.3.4. General Surgery
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Clinics
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Surgical Sutures Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Absorbable
  • 7.1.2. Non-Absorbable
• 7.2. Market Analysis, Insights and Forecast - By Form
  • 7.2.1. Natural
  • 7.2.2. Synthetic
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Gynecology
  • 7.3.2. Cardiology
  • 7.3.3. Orthopedics
  • 7.3.4. General Surgery
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Clinics
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. U.K
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Surgical Sutures Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Absorbable
  • 8.1.2. Non-Absorbable
• 8.2. Market Analysis, Insights and Forecast - By Form
  • 8.2.1. Natural
  • 8.2.2. Synthetic
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Gynecology
  • 8.3.2. Cardiology
  • 8.3.3. Orthopedics
  • 8.3.4. General Surgery
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Clinics
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Surgical Sutures Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Absorbable
  • 9.1.2. Non-Absorbable
• 9.2. Market Analysis, Insights and Forecast - By Form
  • 9.2.1. Natural
  • 9.2.2. Synthetic
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Gynecology
  • 9.3.2. Cardiology
  • 9.3.3. Orthopedics
  • 9.3.4. General Surgery
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Clinics
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Surgical Sutures Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Absorbable
  • 10.1.2. Non-Absorbable
• 10.2. Market Analysis, Insights and Forecast - By Form
  • 10.2.1. Natural
  • 10.2.2. Synthetic
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Gynecology
  • 10.3.2. Cardiology
  • 10.3.3. Orthopedics
  • 10.3.4. General Surgery
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Clinics
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. B. Braun SE
    • 11.2.1.1. Overview
    • 11.2.1.2. Product
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. financials (Based on Availability)
  • 11.2.2. Johnson & Johnson Services, Inc.
    • 11.2.2.1. Overview
    • 11.2.2.2. Product
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. financials (Based on Availability)
  • 11.2.3. Smith + Nephew
    • 11.2.3.1. Overview
    • 11.2.3.2. Product
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. financials (Based on Availability)
  • 11.2.4. Medtronic
    • 11.2.4.1. Overview
    • 11.2.4.2. Product
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. financials (Based on Availability)
  • 11.2.5. Coloplast A/S
    • 11.2.5.1. Overview
    • 11.2.5.2. Product
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. financials (Based on Availability)
  • 11.2.6. Apollo Endosurgery, Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Product
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. financials (Based on Availability)
  • 11.2.7. Boston Scientific Corporation
    • 11.2.7.1. Overview
    • 11.2.7.2. Product
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. financials (Based on Availability)
  • 11.2.8. DemeTECH Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Product
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. financials (Based on Availability)
  • 11.2.9. TEPHA INC.
    • 11.2.9.1. Overview
    • 11.2.9.2. Product
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. financials (Based on Availability)
  • 11.2.10. Internacional Farmaceutica
    • 11.2.10.1. Overview
    • 11.2.10.2. Product
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. financials (Based on Availability)
  • 11.2.11. Kono Seisakusho Co., Ltd.
    • 11.2.11.1. Overview
    • 11.2.11.2. Product
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. financials (Based on Availability)
  • 11.2.12. CONMED Corporation
    • 11.2.12.1. Overview
    • 11.2.12.2. Product
    • 11.2.12.3. SWOT Analysis
    • 11.2.12.4. Recent Developments
    • 11.2.12.5. Strategies
    • 11.2.12.6. financials (Based on Availability)